___

• Wyllie, E., 2015. Wyllie’s Treatment of Epilepsy: Principles and Practice, sixth edition. Wolters Kluwer Health.
• Motamedi, G., Meador, K., 2003. Epilepsy and cognition. Epilepsy Behav. 4 (Suppl. 2), S25–38.
• Schmidt, D., 2009. Drug treatment of epilepsy: options and limitations. Epilepsy Behav. 15, 56–65.
• Eddy, C.M., Rickards, H.E., Cavanna, A.E., 2011. The cognitive impact of antiepileptic drugs. Ther. Adv. Neurol. Disord. 4, 385–407.
• Kanner, A.M., et al., 2012. Depression and epilepsy: epidemiologic and neurobiologic perspectives that may explain their high comorbid occurrence. Epilepsy Behav. 24, 156–168.
• Chang, B.S., Lowenstein, D.H., 2003. Epilepsy. N. Engl. J. Med. 349, 1257–1266.
• Cowan, L.D., 2002. The epidemiology of the epilepsies in children. Ment. Retard. Dev. Disabil. Res. Rev. 8, 171–181.
• Reddy, D.S., Kuruba, R., 2013. Experimental models of status epilepticus and neuronal injury for evaluation of therapeutic interventions. Int. J. Mol. Sci. 14, 18284–18318.
• Shin, E.-J., et al., 2011. Role of oxidative stress in epileptic seizures. Neurochem. Int. 59, 122–137.
• Hancock, J.T., Desikan, R., Neill, S.J., 2001. Role of reactive oxygen species in cell signaling pathways. Biochem. Soc. Trans. 29, 345–350.
• Elger, C.E., Helmstaedter, C., Kurthen, M., 2004. Chronic epilepsy and cognition. Lancet Neurol. 3, 663–672.
• Curia, G., et al., 2014. Pathophysiogenesis of mesial temporal lobe epilepsy: is prevention of damage antiepileptogenic? Curr. Med. Chem. 21, 663–688.
• Kang, J.-Q., Macdonald, R.L., 2009. Making sense of nonsense GABA(A) receptor mutations associated with genetic epilepsies. Trends Mol. Med. 15, 430–438.
• Olsen, R.W., DeLorey, T.M., Gordey, M., Kang, M.H., 1999. GABA receptor function and epilepsy. Adv. Neurol. 79, 499–510.
• McNamara, J.O., Huang, Y.Z., Leonard, A.S., 2006. Molecular signaling mechanisms underlying epileptogenesis. Sci. STKE re12 (2006).
• Nalivaiko, E., Michaud, J.C., Soubrié, P., Le Fur, G., Feltz, P., 1997. Tachykinin neurokinin-1 and neurokinin-3 receptor-mediated responses in guinea-pig substantia nigra: an in vitro electrophysiological study. Neuroscience 78, 745–757.
• Liu, H., Mazarati, A.M., Katsumori, H., Sankar, R., Wasterlain, C.G., 1999. Substance P is expressed in hippocampal principal neurons during status epilepticus and plays a critical role in the maintenance of status epilepticus. Proc. Natl. Acad. Sci. U. S. A. 96, 5286–5291.
• Penix, L.P., Thompson, K.W., Wasterlain, C.G., 1996. Selective vulnerability to perforant path stimulation: role of NMDA and non-NMDA receptors. Epilepsy Res. Suppl. 12, 63–73.
• Silvestrini B, Pozzatti C. Pharmacological properties of 3-phenyl-5β diethylaminoethyl-1, 2, 4-oxadiazole. Br J Pharmacol Chemother 1961; 16: 209-217.
• Erbaş, O., Solmaz, V., Aksoy, D., 2015. Inhibitor effect of dexketoprofen in rat model of pentylenetetrazol-induced seizures. Neurol. Res. 37, 1096–1101.
• Kubin, L., Alheid, G.F., Zuperku, E.J., McCrimmon, D.R., 2006. Central pathways of pulmonary and lower airway vagal afferents. J. Appl. Physiol. 101, 618–627.
• Aeby, A., Poznanski, N., Verheulpen, D., Wetzburger, C., Van Bogaert, P., 2005. Levetiracetam efficacy in epileptic syndromes with continuous spikes and waves during slow sleep: experience in 12 cases. Epilepsia 46, 1937–1942.
• Fernández, I.S., et al., 2012. Clinical staging and electroencephalographic evolution of continuous spikes and waves during sleep. Epilepsia 53, 1185–1195.
• Lüttjohann, A., Fabene, P.F., van Luijtelaar, G., 2009. A revised Racine’s scale for PTZ-induced seizures in rats. Physiol. Behav. 98, 579–586.
• Canning, B.J., 2007. Encoding of the cough reflex. Pulm. Pharmacol. Ther. 20, 396–401.
• Walker, B.R., Easton, A., Gale, K., 1999. Regulation of limbic motor seizures by GABA and glutamate transmission in nucleus tractus solitarius. Epilepsia 40, 1051–1057.
• Epilepsy. World Health Organization. Erişim linki: http://www.who.int/news-room/factsheets/detail/epilepsy. (Erişim tarihi: 10 Aralık 2019).
• Avoli, M., et al., 2002. Network and pharmacological mechanisms leading to epileptiform synchronization in the limbic system in vitro. Prog. Neurobiol. 68, 167–207.
• Mantegazza, M., Curia, G., Biagini, G., Ragsdale, D.S., Avoli, M., 2010. Voltage-gated sodium channels as therapeutic targets in epilepsy and other neurological disorders. Lancet Neurol. 9, 413–424.
• Badawy, R.A.B., Harvey, A.S., Macdonell, R.A.L., 2009. Cortical hyperexcitability and epileptogenesis: understanding the mechanisms of epilepsy - part 1. J. Clin. Neurosci. 16, 355–365.
• Werner, F.-M., Coveñas, R., 2011. Classical neurotransmitters and neuropeptides involved in generalized epilepsy: a focus on antiepileptic drugs. Curr. Med. Chem. 18, 4933–4948.
• Meldrum, B.S., 1995. Neurotransmission in epilepsy. Epilepsia 36 (Suppl. 1), S30–35.
• Bolser, D.C., Poliacek, I., Jakus, J., Fuller, D.D., Davenport, P.W., 2006. Neurogenesis of cough, other airway defensive behaviors and breathing: A holarchical system? Respir. Physiol. Neurobiol. 152, 255–265.
• Polverino, M., et al., 2012. Anatomy and neuro-pathophysiology of the cough reflex arc. Multidiscip. Respir. Med. 7, 5.
• Canning, B.J., Mori, N., 2011. Encoding of the cough reflex in anesthetized guinea pigs. Am. J. Physiol. Regul. Integr. Comp. Physiol. 300, R369–377.
• Coleridge, J.C., Coleridge, H.M., 1984. Afferent vagal C fibre innervation of the lungs and airways and its functional significance. Rev. Physiol. Biochem. Pharmacol. 99, 1–110.
• Shannon, R., Baekey, D.M., Morris, K.F., Lindsey, B.G., 1998. Ventrolateral medullary respiratory network and a model of cough motor pattern generation. J. Appl. Physiol. 84, 2020–2035.
• Shannon, R., Baekey, D.M., Morris, K.F., Li, Z., Lindsey, B.G., 2000. Functional connectivity among ventrolateral medullary respiratory neurones and responses during fictive cough in the cat. J. Physiol. (Lond.) 525 (Pt 1), 207–224.
• Canning, B.J., et al., 2014. Anatomy and neurophysiology of cough: CHEST Guideline and Expert Panel report. Chest 146, 1633–1648.
• Jhamandas, J.H., Harris, K.H., 1992. Excitatory amino acids may mediate nucleus tractus solitarius input to rat parabrachial neurons. Am. J. Physiol. 263, R324–330.
• Rutecki, P., 1990. Anatomical, physiological, and theoretical basis for the antiepileptic effect of vagus nerve stimulation. Epilepsia 31 (Suppl 2), S1–6.
• Havaldar FH, Patil AR (2009) Synthesis of biologically active 3-[4-(4-substituted amino-4-yl-methyl-5-thione[1,3,4]-oxadiazole-2-yl-methoxy)-phenyl]-2-phenyl-3H-quinazolin-4-ones. Asian J Chem 21:5267–5272.
• Mehta DK, Das R, Dua K (2009) Synthesis, antimicrobial and anti-inflammatory activity of some new 1,3,4-oxadiazoles and 1,3,4-oxadiazole-2-thione derivatives as mannich bases containing furan moiety. Int J Chem Sci 7:225–234.
• Nagalakshmi G (2008) Synthesis, antimicrobial and anti-inflammatory activity of 2,5-disubstituted-1,3,4-oxadiazoles. Indian J Pharm Sci 70:49–55.
• Husaini A, Ahmad FJ, Ajmal M, Ahuja P (2008) Synthesis of 1-(4-phenoxyphenyl)-3-[5-(substituted aryl)-1,3,4-oxadiazol-2-yl]propan-1-ones as safer anti-inflammatory and analgesic agents. J Serb Chem Soc 73:781–791.
• George S, Parameswaran MK, Chakraborty AR, Ravi TK (2008) Synthesis and evaluation of the biological activities of some 3-{[5-(6-methyl-4-aryl-2-oxo-1,2,3,4-tetrahydropyrimidine-5-yl)-1,3,4-oxadiazol-2-yl]-imino}-1,3-dihydro-2H-indol-2-one derivatives. Acta Pharm 58:119–129.
• Mishra AR, Singh DV, Mishra RM (2005) Synthesis and antifungal activity of new 1,3,4-oxadiazolo[3,2-b]-s-triazine-5-ones and their thiones analogues. Indian J Heterocycl Chem 14:289–292.
• Girges MM (1994) Synthesis and pharmacological evaluation of novel series of sulfonate ester-containing 1,3,4-oxadiazole derivatives with anticipated hypoglycemic activity. Arzneimittelforschung 44:490–495.
• Revanasiddappa BC, Subrahmanyam EVS (2009) Chloramine-T mediated synthesis of 1,3,4-oxadiazoles. Orient J Chem 25:707–710.
• Maslat AO, Abussaud M, Tashtoush H, Al-Taalib M (2002) Synthesis, antibacterial, antifungal and genotoxic activity of bis-1,3,4-oxadiazole derivatives. Pol J Pharmacol 54:55–59.
• Borg, S., Luthman, K., Nyberg, F., Terenius, L., & Hacksell, U. (1993). 1, 2, 4-Oxadiazole derivatives of phenylalanine: potential inhibitors of substance P endopeptidase. European journal of medicinal chemistry, 28(10), 801-810.
• Lankau, H. J., Unverferth, K., Grunwald, C., Hartenhauer, H., Heinecke, K., Bernöster, K., ... & Rundfeldt, C. (2007). New GABA-modulating 1, 2, 4-oxadiazole derivatives and their anticonvulsant activity. European journal of medicinal chemistry, 42(6), 873-879.
• S.J. Gilani, O. Alam, S.A. Khan, N. Siddiqui, H. Kumar, Der Pharmacia Lettre, 2009, 1, 1-8.
• A. Zarghi, S. Hamedi, F. Tootooni, B. Amini, B. Sharifi, M. Faizi, S.A. Tabatabai, A. Shafiee, Sci Pharm., 2008, 76, 185–201.